PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers

Nephrology Dialysis Transplantation

Volumn 23, Issue 8, 2008, Pages 2563-2570

  Pasch, Andreas ^a   Frey, Felix J ^a   Eisenberger, Ute ^a   Mohaupt, Markus G ^a   Bonny, Olivier ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

1.25 vitamin D; Bone mineral density; Hypercalciuria; Nephrolithiasis; Parathyroid hormone

Indexed keywords

CALCIUM; PARATHYROID HORMONE; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; CALCIUM HOMEOSTASIS; CALCIUM URINE LEVEL; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HYPERCALCIURIA; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; BONE DENSITY; CALCITRIOL; CALCIUM; CALCIUM, DIETARY; COHORT STUDIES; FEMALE; HUMANS; HYPERCALCIURIA; KIDNEY CALCULI; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROSPECTIVE STUDIES;

EID: 48749110967     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn091     Document Type: Article

References (33)

1. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115: 2598-2608
2. Bataille P, Achard JM, Fournier A et al. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 1991; 39: 1193-1205
3. Borghi L, Meschi T, Guerra A et al. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 1991; 146: 1334-1338
4. Pietschmann F, Breslau NA, Pak CYC. Reduced vertebral bone density in hypercalciuric urolithiasis. J Bone Miner Res 1992; 7: 1383-1388
5. Jaeger P, Lippuner K, Casez JP et al. Low bone mass in idiopathic renal stone formers: Magnitude and significance. J Bone Miner Res 1994; 9: 1525-1532
6. Lawoyin S, Sismilich S, Browne R et al. Bone mineral content in patients with calcium urolithiasis. Metabolism 1979; 28: 1250-1254
7. Fuss M, Gillet C, Simon J et al. Bone mineral content in idiopathic renal stone disease and in primary hyperparathyreoidismus. Eur Urol 1983; 9: 32-34
8. Pacifici R, Rothstein M, Rifas L et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990; 71: 138-145
9. Melton III LJ, Crowson CS, Khosla S et al. Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 1998; 53: 459-464
10. Lauderdale DS, Thisted RA, Wen M et al. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 2001; 16: 1893-1898
11. Pak CYC, Kaplan R, Bone Townsend J et al. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. New Engl J Med 1975; 292: 497-500
12. Pak CY, Britton F, Peterson R et al. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 1980; 69: 19-30
13. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995; 98: 50-59
14. Ghazali A, Fuentes V, Desaint C et al. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 1997; 82: 32-38
15. Broadus AE, Insogna KL, Lang R et al. Evidence for disordered control of 1,25-(OH)2D production in absorptive hypercalciuria. N Engl J Med 1984; 311: 73-80
16. Insogna K, Broadus A, Dreyer B et al. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 1985; 3: 490-495
17. Filipponi P, Mannarelli C, Pacifici R et al. Evidence for a prostaglandin mediated bone responsive mechanism in subjects with fasting hypercalciuria. Calcif Tissue Int 1988; 43: 61-66
18. Asplin JR, Donahue S, Kinder J et al. Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int 2006; 70: 1463-1467
19. Moe O, Bonny O. Genetic hypercalciuria. J Am Soc Nephrol 2005; 16: 729-745
20. Reid I, Ames R, Orr-Walker B et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 2000; 109: 362-370
21. LaCroix A, Ott S, Ichikawa L et al. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 133: 516-526
22. Rejnmark L, Vestergaard P, Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 2005; 76: 167-175
23. Slatopolsky E, Finch J, Denda M et al. Phosphate restriction prevents parathyroid cell growth in uremic rats. High phosphate directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97: 2534-2540
24. Portale A, Halloran B, Murphy M et al. Oral intake of phosphorus can determine the serum concentration of 1,25-(OH)2D by determining its production rate in humans. J Clin Invest 1986; 77: 7-12
25. Yamamoto M, Igarashi T, Muramatsu M et al. Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat. J Clin Invest 1989; 83: 1053-1056
26. Trechsel U, Eisman JA, Fischer JA et al. Calcium dependent parathyroid hormone-independent regulation of 1,25-(OH)2D. Am J Physiol 1980; 239: E119-E124
27. Bone HI, Zerwekh J, Haussler M et al. Effect of parathyroidectomy on serum 1,25-(OH)2D and intestinal calcium absorption in primary hyperparathyroidism. J Clin Endocrinol Metab 1979; 48: 877-879
28. Kinyamu H, Gallagher J, Petranick K et al. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women. J Bone Miner Res 1996; 11:1400-1405
29. Ro H, Tembe V, Krug T et al. Acidosis inhibits 1,25-(OH)2D3 but not cAMP production in response to parathyroid hormone in the rat. J Bone Miner Res 1990; 5: 173-278
30. Beckerman P, Silver J. Vitamin D and the parathyroid. Am J Med Sci 1999; 317: 363-369
31. Bouillon R, van Baelen H, de Moor P. Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem 1980; 13: 1029-1034
32. De Moor P, Louwagie A, Faict D et al. Steroid-carrier proteins in patients with multiple myeloma. J Steroid Biochem 1986; 25: 261-264
33. Kurz P, Monier-Faugere M, Bognar B et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994; 46: 855-861